Hematology
1428 articles · 38 journals
Journals in this subcategory (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (86)
- Thrombosis Research · Elsevier (81)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- British Journal of Haematology · Wiley (78)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (73)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (68)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (64)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Transfusion · Wiley (53)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (8)
- Leukemia · Springer Nature (8)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- How do I manage catastrophic failure of liquid nitrogen storage for human cells, tissues, and cellular and tissue‐based products?
- Red Blood Cell Exchange in a Resource‐Variable Setting: A Scoping Review of Two Decades of Indian Experience
-
Patient‐Reported Symptom Burden and Objective Responses After Belumosudil in Heavily Pretreated Chronic GvHD
ABSTRACT Background Belumosudil has demonstrated clinical activity in chronic graft‐versus‐host disease (cGvHD), but its impact on patient‐reported symptom burden in routine practice remains incompletely characterized. Objective To...
-
NPM1‐mutated AML: One entity, multiple layers of heterogeneity
Nucleophosmin 1 ( NPM1 ) mutations are found in around one third of all acute myeloid leukaemias (AMLs). However, little is known about the clinical role of the rare, non‐A NPM1 variants. Sangiorgio et al. showed that rare variants...
- Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia
-
Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)
Blood Cancer Journal, Published online: 11 November 2026; doi:10.1038/s41408-026-01641-5 Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)
-
Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
Leukemia, Published online: 11 November 2026; doi:10.1038/s41375-026-03173-0 Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML
-
Orelabrutinib plus R‐CHOP in patients with newly diagnosed non‐GCB double‐expressor DLBCL: A single‐arm, phase II study
Summary Double‐expressor diffuse large B‐cell lymphoma (DE‐DLBCL) patients, defined by co‐expression of MYC proto‐oncogene protein (≥40%) and B‐cell lymphoma 2 protein (≥50%), typically have poor outcomes with the traditional first‐line...
- Response to venetoclax‐containing regimens in patients with relapsed/refractory (R/R) T‐cell acute lymphoblastic leukaemia (T‐ALL) and lymphoblastic lymphoma (T‐LBL)
- Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome
-
Development of a novel manufacturing process for highly purified and stable immunoglobulin M with enhanced plasma utilization
Abstract Background and Objectives Immunoglobulin M (IgM) is a promising therapeutic agent. However, its production is limited by high molecular weight, complex structure and poor stability. This study aimed to develop a novel...
- Collection efficiency of hematopoietic cells by apheresis after mobilization in a single centre: Analysis of the last 15 years
- Why donors intend to return: Motivation, satisfaction and post‐donation intention in a high‐demand tertiary hospital setting in Lagos, Nigeria
- Compensated iron depletion in repeated blood donations: Stability of circulating microRNAs despite reduced ferritin stores
- Transforming thalassaemia care in India through virtual capacity building: Evolution of a national training initiative using extension for community healthcare outcomes model
- Opportunities for vein‐to‐vein datasets from a blood establishment perspective: Towards a ‘Pan‐European Transfusion Research InfrAstructure’
- Hepatitis E virus seroepidemiology among Malaysian blood donors: Prevalence and associated risk factors
- Mapping syphilis surveillance: Insights into blood donation screening practices worldwide
- Comparing the volume of umbilical cord blood collection using different techniques
- HIV incidence and correlates of incident infection among Brazilian blood donors following adoption of individual donor assessment
- Design, development and implementation of a new transfusion safety system at the Banc de Sang i Teixits in Catalonia (Spain)
- Evaluation of the in vitro quality of X‐ray irradiated red cell concentrates processed and stored using di(2‐ethylhexyl) terephthalate plasticized blood bag sets
- Exploring intraoperative autotransfusion in a blood desert: A single‐centre study in Turkana County, Kenya
- Identification of a novel high‐prevalence red blood cell antigen on junctional adhesion molecule‐A defines a new blood group system
- Identification of thrombotic complications of the arm in blood donors: Evidence from literature and national data
- Public perspectives on potential changes to malaria deferral criteria in Canada
- Evaluation of data from the hPSCreg®, a global registry for human pluripotent stem cell lines (hPSC‐lines)
- Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023)
- Beyond universal mitigation: Risk‐stratified approaches for preventing vasovagal reactions in blood donors
- Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’